[pubmed] Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline

Intégration des publications parues sur PUBMED
Répondre
Avatar du membre

Auteur du sujet
RSS-Bot
Ami(e) de Diamant
Ami(e) de Diamant
Messages : 2985
Enregistré le : 31 mai 2020 09:57
3
Zodiaque :
Âge : 20
Contact :
    Windows 10 Edge

[pubmed] Case Report: Treatment of Myasthenic Ptosis with Topical Ocular Oxymetazoline

Message par RSS-Bot »


Optom Vis Sci. 2021 Sep 9. doi: 10.1097/OPX.0000000000001800. Online ahead of print.

ABSTRACT

SIGNIFICANCE: Ptosis is often the hallmark finding in ocular and general myasthenia gravis. Reduction of ptosis has been achieved with oral and topical ocular medications. However, these medications can result in systemic and ocular side effects. A novel eye drop appears to be effective in reducing ptosis while minimizing side effects.

PURPOSE: This case report aimed to demonstrate the efficacy of topical oxymetazoline hydrochloride 0.1%, an alpha-adrenergic agonist in temporary elimination of ptosis associated with myasthenia gravis.

CASE REPORT: A 68-year-old female with a history of myasthenia gravis and longstanding ptosis in the right eye presented to improve the asymmetrical appearance of her eyelids. One drop of oxymetazoline hydrochloride 0.1% was instilled in the right eye of the patient. Within two hours, the ptosis was eliminated, the margin-reflex distance 1 increased by 2.0 mm, and the superior visual field measured by a superior 36-point screening test increased by 15 points. The effect lasted for at least 7 hours. Of note, there was a decrease in elevation of the contralateral non-ptotic eyelid that did not receive a drop of oxymetazoline, which might occur only in myasthenia gravis. Further evaluation is warranted.

CONCLUSIONS: Oxymetazoline 0.1% is effective in reducing and potentially eliminating ptosis related to ocular myasthenia gravis for up to 7 hours.

PMID:34510144 | DOI:10.1097/OPX.0000000000001800


Source: https://pubmed.ncbi.nlm.nih.gov/3451014 ... 1&v=2.14.5
Si vous appréciez notre travail, merci de nous soutenir un petit don en cliquant ICI

Pour obtenir la traduction en français,
cliquez sur le bouton situé dans la barre des menus en haut de cette page 

Image


Pour les donateurs, si cet article vous intéresse, nous pouvons faire l’acquisition d'un tiré-à-part.
Merci d'en faire la demande sur association.amis-modo@myasthenie.com


Bonne lecture...
Répondre

Retourner vers « Echos de la recherche »